Displaying archives for 2013 January:

EGFR doesn’t predict outcomes in lung cancer

Posted by Samantha Powell on January 25th, 2013 | No comments

EGFR doesn’t predict outcomes in lung cancer Delicia Honen Yard January 25, 2013 Mutation in the epidermal growth factor receptor (EGFR) gene is not a prognostic factor in persons with non-small cell lung cancer (NSCLC) who have undergone surgical resection or who have received conventional therapies to fight a recurrence, researchers have discovered. However, after […]

Boehringer Ingelheim’s lung cancer compound granted FDA Priority Review

Posted by Samantha Powell on January 17th, 2013 | No comments

Boehringer Ingelheim’s lung cancer compound granted FDA Priority Review Hannah Blake, pharmaphorum The US FDA has granted Priority Review for Boehringer Ingelheim’s New Drug Application for its investigational oncology compound, afatinib. The application for afatinib is currently under review for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with […]

Cancer Rate Soaring, New Chinese Report Reveals

Posted by Samantha Powell on January 15th, 2013 | No comments

Cancer Rate Soaring, New Chinese Report Reveals By Gao Hao & Gary Pansey Epoch Times Staff Every minute, six people in China are diagnosed with cancer, according to the National Central Cancer Registry’s 2012 Annual Report. There has also been an increase in cancer and deaths due to the disease in younger patients over the […]

Reduce Lung Cancer Risk in 2013 by Testing Your Home for Radon Gas / Elevated radon levels found in roughly 1 in 15 homes nationwide

Posted by Samantha Powell on January 14th, 2013 | No comments

Reduce Lung Cancer Risk in 2013 by Testing Your Home for Radon Gas / Elevated radon levels found in roughly 1 in 15 homes nationwide Contact Information: Molly Hooven, Hooven.Molly@epa.gov, 202-564-2313, 202-564-4355. En español: Lina Younes, younes.lina@epa.gov, 202-564-9924, 202-464-4355 WASHINGTON –A As part of National Radon Action Month, the U.S. Environmental Protection Agency (EPA) announced […]

Common Heart Drug Might Improve Lung Cancer Survival

Posted by Samantha Powell on January 9th, 2013 | No comments

Common Heart Drug Might Improve Lung Cancer Survival Beta blockers may slow the spread of the disease, researchers report WEDNESDAY, Jan. 9 (HealthDay News) — New research suggests that beta blockers, medications that are used to control blood pressure and heart rhythms, may also help lung cancer patients live longer. The researchers found that patients […]

FDA grants ‘fast track’ status to GTx lung cancer drug

Posted by Samantha Powell on January 8th, 2013 | No comments

FDA grants ‘fast track’ status to GTx lung cancer drug Michael Sheffield, Staff writer- Memphis Business Journal   The U.S. Food and Drug Administration has granted Fast Track development status to Enobosarm, a drug developed by GTx Inc. Fast Track status is an FDA process that accelerates the development and expedites review of new drugs […]

American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care

Posted by Samantha Powell on January 7th, 2013 | No comments

American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care Mary S. McCabe, Smita Bhatia, Kevin C. Oeffinger, Gregory H. Reaman, Courtney Tyne, Dana S. Wollins, and Melissa M. Hudson Introduction: Over the past several decades, the number of cancer survivors has increased dramatically as a result of improved early detection of first malignancies […]